BioSpace News Archive

Company Anticipates Earlier Than Expected Preliminary Data Readout in August 2020

The Trendlines Group Ltd., is pleased to announce that its newly-formed fund, Trendlines Agrifood Fund Pte. Ltd., has made its first investment, investing in Equinom Ltd, a seed breeding technology business..

Patients Significantly Reduced Hypoglycemic and High Glycemic Events by 50% and 40%, respectively, over a Two-Year Period

Blueprint Medicines Corporation announced its participation in fireside chats at the following upcoming investor conferences

BRIDGEWATER, N.J. , Feb. 19, 2020 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that Will Lewis, Chairman and Chief Executive Officer of Insmed, will present at the 9 th Annual SVB Leerink Global Healthcare Conference in New York, NY on We

REDWOOD CITY, Calif. , Feb. 19, 2020 /PRNewswire/ -- Bolt Biotherapeutics, a private biotechnology company focused on using its Immune-Stimulating Antibody Conjugate (ISAC) platform technology to harness the power of the immune system to treat cancer, today announced that Randall C. Schatzman , PhD., Chief Executive Officer, will present at the SVB Leerink 9 th Annual Global

Cleveland Clinic, Mayo Clinic, St. Jude Children’s Research Hospital Claim Top Spots

FREMONT, Calif. , Feb. 19, 2020 /PRNewswire/ -- Ardelyx, Inc. (NASDAQ: ARDX) today announced that Mike Raab , president and chief executive officer of Ardelyx, will present at the 9 th Annual SVB Leerink Global Healthcare Conference at 3:30 p.m. ET on Wednesday , Feb. 26, 2020 in New York City . To access the live webcast of Ardely

Feb. 19, 2020 13:00 UTC Presentation and webcast to take place at 9:00 a.m. ET on February 26 CAMBRIDGE, Mass.--( BUSINESS WIRE )-- Axcella (Nasdaq: AXLA), a clinical-stage biotechnology company focused on leveraging endogenous metabolic modulators (EMMs) to pioneer a new approach for treating complex diseases and improving health, today announced that management will be presenting at the SVB Leerink 9th Annual Global Healthcare Conference in New York City on February 26,

Feb. 19, 2020 13:04 UTC CHARLESTON, S.C. & OAKDALE, Minn.--( BUSINESS WIRE )-- Veravas, Inc. , a diagnostic company founded in Charleston, S.C., announced today a significant milestone, reaching a total of $4 million in funding from private investors through the issuance of convertible notes. Veravas develops proprietary sample pretreatment products and new diagnostic tests to provide laboratories with high-value solutions for the accurate diagnoses of some of the world’